Detalhe da pesquisa
1.
Repression of CTSG, ELANE and PRTN3-mediated histone H3 proteolytic cleavage promotes monocyte-to-macrophage differentiation.
Nat Immunol
; 22(6): 711-722, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34017121
2.
Chemical linguistics: Reading the modified proteome.
Mol Cell
; 81(12): 2501-2503, 2021 06 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-34143967
3.
Direct readout of heterochromatic H3K9me3 regulates DNMT1-mediated maintenance DNA methylation.
Proc Natl Acad Sci U S A
; 117(31): 18439-18447, 2020 08 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32675241
4.
Overcoming acquired resistance to cetuximab by dual targeting HER family receptors with antibody-based therapy.
Mol Cancer
; 13: 242, 2014 Oct 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-25344208
5.
Targeting HER3-dependent activation of nuclear AKT improves radiotherapy of non-small cell lung cancer.
Radiother Oncol
; 174: 92-100, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35839938
6.
DNMT1 reads heterochromatic H4K20me3 to reinforce LINE-1 DNA methylation.
Nat Commun
; 12(1): 2490, 2021 05 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33941775
7.
Multivalent tumor suppressor adenomatous polyposis coli promotes Axin biomolecular condensate formation and efficient ß-catenin degradation.
Sci Rep
; 10(1): 17425, 2020 10 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33060621
8.
Binding to medium and long chain fatty acyls is a common property of HEAT and ARM repeat modules.
Sci Rep
; 9(1): 14226, 2019 10 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31578417
9.
RETRACTED: The receptor tyrosine kinase AXL mediates nuclear translocation of the epidermal growth factor receptor.
Sci Signal
; 10(460)2017 01 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28049763
10.
Retraction.
Sci Signal
; 14(708): eabn0168, 2021 Nov 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34752142
11.
Targeting the HER Family with Pan-HER Effectively Overcomes Resistance to Cetuximab.
Mol Cancer Ther
; 15(9): 2175-86, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27422810
12.
AXL Is a Logical Molecular Target in Head and Neck Squamous Cell Carcinoma.
Clin Cancer Res
; 21(11): 2601-12, 2015 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25767293
13.
Correction: AXL Is a Logical Molecular Target in Head and Neck Squamous Cell Carcinoma.
Clin Cancer Res
; 24(23): 6099, 2018 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30510088